Difference between revisions of "Team:Munich/Safety"

Line 70: Line 70:
 
<p class="introduction">
 
<p class="introduction">
 
Since our project’s ultimate goal is to diagnose infectious diseases, we thoroughly addressed safety aspects of our work. Originally we had an intention to work with saliva samples, but since our lab has S1 biosafety level, we had to find another solution. So we decided to obtain RNA of non-pathogenic parts of <i>B.subtilis</i>, Norwalk virus and Hepatitis virus by method of <i>in vitro</i> transcription. Besides that we work with <i>E.coli</i> only. </p>
 
Since our project’s ultimate goal is to diagnose infectious diseases, we thoroughly addressed safety aspects of our work. Originally we had an intention to work with saliva samples, but since our lab has S1 biosafety level, we had to find another solution. So we decided to obtain RNA of non-pathogenic parts of <i>B.subtilis</i>, Norwalk virus and Hepatitis virus by method of <i>in vitro</i> transcription. Besides that we work with <i>E.coli</i> only. </p>
<p>More details about regulations and law can be found in our Safety Form.                </p>
+
<p>More details about regulations, law and safety aspects of our work can be found in our Safety Form.                </p>
  
 
</td>
 
</td>

Revision as of 15:24, 1 November 2017


Safety

Since our project’s ultimate goal is to diagnose infectious diseases, we thoroughly addressed safety aspects of our work. Originally we had an intention to work with saliva samples, but since our lab has S1 biosafety level, we had to find another solution. So we decided to obtain RNA of non-pathogenic parts of B.subtilis, Norwalk virus and Hepatitis virus by method of in vitro transcription. Besides that we work with E.coli only.

More details about regulations, law and safety aspects of our work can be found in our Safety Form.